What Is Revenue (TTM)?

Revenue (TTM) stands for 'Revenue Trailing Twelve Months' and represents the total revenue a company has generated over the most recent 12-month period. This metric provides investors and analysts with a current snapshot of a company's financial performance by using the latest available quarterly data rather than waiting for annual reports. For cannabis companies, TTM revenue is particularly valuable given the industry's rapid growth and evolving regulatory landscape. Unlike traditional annual revenue figures that may reflect outdated market conditions, TTM revenue captures the most recent business performance, including seasonal fluctuations, new market entries, and regulatory changes that significantly impact cannabis operations. TTM revenue is calculated by adding the revenue from the four most recent quarters. For example, if examining a cannabis company in Q3 2024, TTM revenue would include Q4 2023, Q1 2024, Q2 2024, and Q3 2024. This rolling calculation ensures the metric always reflects the most current 12 months of business activity. In the cannabis sector, TTM revenue is especially important because companies often experience significant quarter-over-quarter growth due to market expansion, new product launches, or entry into newly legalized markets. Major cannabis operators like Curaleaf reported TTM revenue of approximately $1.3 billion in 2023, while Trulieve generated over $1 billion in TTM revenue during the same period. Investors use TTM revenue to evaluate cannabis companies' growth trajectories, compare performance across the sector, and calculate important financial ratios like price-to-sales (P/S) multiples. However, TTM revenue should be analyzed alongside other metrics like gross margins, EBITDA, and cash flow, as the cannabis industry faces unique challenges including high tax burdens, regulatory compliance costs, and limited banking access. *Disclaimer: This information is for educational purposes only and does not constitute investment advice. Cannabis investments carry significant risks, and past performance does not guarantee future results.*